228 related articles for article (PubMed ID: 11776406)
21. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.
Proctor DM; Suh M; Campleman SL; Thompson CM
Toxicology; 2014 Nov; 325():160-79. PubMed ID: 25174529
[TBL] [Abstract][Full Text] [Related]
22. Comparative histological studies on liver of mice exposed to Cr(VI) and Cr(V) compounds.
das Neves RP; Santos TM; Pereira Mde L; de Jesus JP
Hum Exp Toxicol; 2002 Jul; 21(7):365-9. PubMed ID: 12269698
[TBL] [Abstract][Full Text] [Related]
23. Chromium hexavalent compounds.
Rep Carcinog; 2004; 11():III63-6. PubMed ID: 21089834
[No Abstract] [Full Text] [Related]
24. An assessment and quantitative uncertainty analysis of the health risks to workers exposed to chromium contaminated soils.
Paustenbach DJ; Meyer DM; Sheehan PJ; Lau V
Toxicol Ind Health; 1991 May; 7(3):159-96. PubMed ID: 1949057
[TBL] [Abstract][Full Text] [Related]
25. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
[TBL] [Abstract][Full Text] [Related]
26. Chromium-induced genotoxicity and interference in human lymphoblastoid cell (TK6) repair processes.
El-Yamani N; Zúñiga L; Stoyanova E; Creus A; Marcos R
J Toxicol Environ Health A; 2011; 74(15-16):1030-9. PubMed ID: 21707427
[TBL] [Abstract][Full Text] [Related]
27. The role of chromium(V) in the mechanism of chromate-induced oxidative DNA damage and cancer.
Sugden KD; Stearns DM
J Environ Pathol Toxicol Oncol; 2000; 19(3):215-30. PubMed ID: 10983888
[TBL] [Abstract][Full Text] [Related]
28. Hexavalent chromium responsible for lung lesions induced by intratracheal instillation of chromium fumes in rats.
Toya T; Fukuda K; Kohyama N; Kyono H; Arito H
Ind Health; 1999 Jan; 37(1):36-46. PubMed ID: 10052298
[TBL] [Abstract][Full Text] [Related]
29. Reduction of chromium(VI) and its relationship to carcinogenesis.
Shi X; Chiu A; Chen CT; Halliwell B; Castranova V; Vallyathan V
J Toxicol Environ Health B Crit Rev; 1999; 2(1):87-104. PubMed ID: 10081526
[TBL] [Abstract][Full Text] [Related]
30. Carcinogenicity of hexavalent chromium.
Holmes AL; Wise SS; Wise JP
Indian J Med Res; 2008 Oct; 128(4):353-72. PubMed ID: 19106434
[TBL] [Abstract][Full Text] [Related]
31. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
Quievryn G; Peterson E; Messer J; Zhitkovich A
Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
[TBL] [Abstract][Full Text] [Related]
32. Chromium.
Barceloux DG
J Toxicol Clin Toxicol; 1999; 37(2):173-94. PubMed ID: 10382554
[TBL] [Abstract][Full Text] [Related]
33. [Molecular effects of chromium compound activity].
Woźniak K
Postepy Hig Med Dosw; 1996; 50(4):383-94. PubMed ID: 9019747
[TBL] [Abstract][Full Text] [Related]
34. Oxidative activation of the human carcinogen chromate by arsenite: a model for synergistic metal activation leading to oxidative DNA damage.
Sugden KD; Rigby KM; Martin BD
Toxicol In Vitro; 2004 Dec; 18(6):741-8. PubMed ID: 15465638
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic insights from the NTP studies of chromium.
Witt KL; Stout MD; Herbert RA; Travlos GS; Kissling GE; Collins BJ; Hooth MJ
Toxicol Pathol; 2013 Feb; 41(2):326-42. PubMed ID: 23334696
[TBL] [Abstract][Full Text] [Related]
36. Chromium(VI) induced alterations in mouse spleen cells: a short-term assay.
das Neves RP; Santos TM; de Pereira ML; de Jesus JP
Cytobios; 2001; 106 Suppl 1():27-34. PubMed ID: 11534826
[TBL] [Abstract][Full Text] [Related]
37. Can the effects of chromium compounds exposure be modulated by vitamins and microelements?
Sijko M; Janasik B; Wąsowicz W; Kozłowska L
Int J Occup Med Environ Health; 2021 Aug; 34(4):461-490. PubMed ID: 33734217
[TBL] [Abstract][Full Text] [Related]
38. Lipoperoxidation products and thiol antioxidants in chromium exposed workers.
Goulart M; Batoréu MC; Rodrigues AS; Laires A; Rueff J
Mutagenesis; 2005 Sep; 20(5):311-5. PubMed ID: 15985443
[TBL] [Abstract][Full Text] [Related]
39. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI).
McCarroll N; Keshava N; Chen J; Akerman G; Kligerman A; Rinde E
Environ Mol Mutagen; 2010 Mar; 51(2):89-111. PubMed ID: 19708067
[TBL] [Abstract][Full Text] [Related]
40. Chromium(VI) enhances (+/-)-anti-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene-induced cytotoxicity and mutagenicity in mammalian cells through its inhibitory effect on nucleotide excision repair.
Hu W; Feng Z; Tang MS
Biochemistry; 2004 Nov; 43(44):14282-9. PubMed ID: 15518579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
